Pore forming polyalkylpyridinium salts from marine sponges versus synthetic lipofection systems: distinct tools for intracellular delivery of cDNA and siRNA by McLaggan, D et al.
        
Citation for published version:
McLaggan, D, Adjimatera, N, Sepcic, K, Jaspars, M, MacEwan, DJ, Blagbrough, IS & Scott, RH 2006, 'Pore
forming polyalkylpyridinium salts from marine sponges versus synthetic lipofection systems: distinct tools for
intracellular delivery of cDNA and siRNA', BMC Biotechnology, vol. 6, no. 6. https://doi.org/10.1186/1472-6750-
6-6
DOI:
10.1186/1472-6750-6-6
Publication date:
2006
Link to publication
Publisher Rights
CC BY
© 2006 McLaggan et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 12. May. 2019
BioMed CentralBMC Biotechnology
ssOpen AcceResearch article
Pore forming polyalkylpyridinium salts from marine sponges versus 
synthetic lipofection systems: distinct tools for intracellular delivery 
of cDNA and siRNA
Debra McLaggan1, Noppadon Adjimatera2, Kristina Sepčić3, Marcel Jaspars4, 
David J MacEwan5, Ian S Blagbrough2 and Roderick H Scott*1
Address: 1School of Medical Sciences, College of Life Sciences and Medicine, University of Aberdeen, Institute of Medical Sciences, Foresterhill, 
Aberdeen AB25 2ZD, UK, 2Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK, 3Department of 
Biology, Biotechnical Faculty, University of Ljubljana, Veèna pot 111, 1000 Ljubljana, Slovenia, 4Marine Natural Products Laboratory, Department 
of Chemistry, University of Aberdeen, Aberdeen AB24 3UE, UK and 5School of Chemical Sciences and Pharmacy, University of East Anglia, 
Norwich, NR4 7TJ, UK
Email: Debra McLaggan - debbie@cabernet.demon.co.uk; Noppadon Adjimatera - prpna@bath.ac.uk; Kristina Sepčić - kristina.sepcic@bf.uni-
lj.si; Marcel Jaspars - m.jaspars@abdn.ac.uk; David J MacEwan - d.macewan@uea.ac.uk; Ian S Blagbrough - i.s.blagbrough@bath.ac.uk; 
Roderick H Scott* - rod.scott@abdn.ac.uk
* Corresponding author    
Abstract
Background: Haplosclerid marine sponges produce pore forming polyalkylpyridinium salts (poly-
APS), which can be used to deliver macromolecules into cells. The aim of this study was to
investigate the delivery of DNA, siRNA and lucifer yellow into cells mediated by poly-APS and its
potential mechanisms as compared with other lipofection systems (lipofectamine and N4,N9-
dioleoylspermine (LipoGen)). DNA condensation was evaluated and HEK 293 and HtTA HeLa cells
were used to investigate pore formation and intracellular delivery of cDNA, siRNA and lucifer
yellow.
Results: Poly-APS and LipoGen were both found to be highly efficient DNA condensing agents.
Fura-2 calcium imaging was used to measure calcium transients indicative of cell membrane pore
forming activity. Calcium transients were evoked by poly-APS but not LipoGen and lipofectamine.
The increases in intracellular calcium produced by poly-APS showed temperature sensitivity with
greater responses being observed at 12°C compared to 21°C. Similarly, delivery of lucifer yellow
into cells with poly-APS was enhanced at lower temperatures. Transfection with cDNA encoding
for the expression enhanced green fluorescent protein was also evaluated at 12°C with poly-APS,
lipofectamine and LipoGen. Intracellular delivery of siRNA was achieved with knockdown in beta-
actin expression when lipofectamine and LipoGen were used as transfection reagents. However,
intracellular delivery of siRNA was not achieved with poly-APS.
Conclusion: Poly-APS mediated pore formation is critical to its activity as a transfection reagent,
but lipofection systems utilise distinct mechanisms to enable delivery of DNA and siRNA into cells.
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The technologies investigated in this study involved the
use of polymeric alkylpyridinium sponge toxins, (poly-
alkylpyridinium salts; poly-APS) [1-3]. Poly-APS is a
marine toxin preparation extracted from the sponge Reni-
era sarai, which can form reversible pores or lesions in cell
membranes [1]. This toxin preparation primarily contains
a cocktail of two polymeric 1,3-octylpyridinium salts of
5.5 and 19 kDa sizes [4]. At a high concentration (50 µg/
ml), polyalkylpyridinium salts can cause irreversible
depolarisation in membrane potential and a collapse in
input resistance. However, at lower concentrations (0.5
µg/ml) poly-APS show reversible actions on the electro-
physiological properties and Ca2+ permeability in HEK
293 cells, dorsal root ganglion neurons and F-11 cells. The
unique pore formation properties in addition to their
poly-positive charged characteristics, could be useful in
non-viral gene therapy (NVGT) applications. In a previous
study [2] some us have shown that sponge toxins can be
used to deliver cDNA into HEK293 cells and that this
results in the expression of the protein encoded by these
genes. Furthermore, the co-transfection of cDNA is stable
and colonies of cells can be produced that contain poly-
APS delivered cDNA and the proteins they encode for [2].
However, there has to date been no reported study on the
interaction of this polycationic toxin with DNA and fur-
ther information is required on the mechanism of trans-
fection and the versatility of macromolecule (DNA or
siRNA) delivery. This is particularly important given that
our data suggest membrane poration is required for poly-
APS-mediated transfection because low molecular weight
pyridinium surfactant monomers and dimers can also be
efficient non-toxic agents for gene delivery [8]. However,
in contrast, pyridinium surfactant monomers are not effi-
cient pore formers and appear to package DNA for deliv-
ery by fusion and/or endocytosis.
The aims of our study were to explore the DNA condensa-
tion properties and temperature sensitivity of their gene
delivery mechanism(s). In addition, the aims were
extended to the delivery, using poly-APS, of small interfer-
ing RNA (siRNA) into cells and thus to the knockdown of
gene expression. Comparisons are made with the activity
of LipoGen, a synthetic lipospermine (see Figure 1) an
efficient DNA delivery agent [5-7], and lipofectamine, a
commercially available transfection reagent.
Results
DNA condensation study of poly-APS and LipoGen
The DNA condensation experiments were run with a plas-
mid encoding for enhanced green fluorescent protein
(pEGFP) or luciferase (pGL3), and with calf thymus DNA
(ctDNA). In DNA condensation experiments, ethidium
bromide (EthBr), a DNA intercalating cationic dye was
used as a fluorescent probe. This intercalation increases
the fluorescence yield of EthBr (excitation 546 nm, emis-
sion 595 nm). Many compounds that bind to DNA,
including DNA condensing agents used in NVGT, can dis-
place EthBr from EthBr-DNA complexes. EthBr has been
widely used to assess the DNA-polyamine complex forma-
tion efficiently [9,10]. In 2000, a modified reproducible
EthBr displacement assay was reported by Geall and Blag-
brough [9]. The excitation wavelength was optimised at
260 nm [11] where EthBr is indirectly excited by energy
transfer from the DNA. The proposed protocol also allows
the experiment to be run without pre-complexing DNA
and its binding molecule, a "displacement assay" [9]. The
DNA condensed particle formation has been measured at
UV absorbance of 320 nm [12]. The double-helical DNA
was bound by polyamines and formed nanoparticles,
which scatter the light resulting in the UV absorbance
increase above 300 nm. Light scattering (LS) is measured
rather than UV absorption (no chromophore for this
wavelength). A little precipitation of the DNA may be vis-
ible, but it does not increase the absorption above 300
nm. The DNA concentration used in this assay was a 10-
fold excess compared to the EthBr assay given the low sen-
sitivity of this experimental system and lack of fluores-
cence indicator.
Both poly-APS and LipoGen (Figure 1) were able to con-
dense pEGFP, pGL3, and ctDNA efficiently with residual
fluorescence at 10 % in ethidium bromide (EthBr) assay
(Figure 2A,B). The increase of UV absorption was also
confirmed by light scattering experiments, indicating
DNA nanoparticle formation (Figure 2C,D). Optimal N/P
Structures of transfection reagents and other related mole-cules of interestFigure 1
Structures of transfection reagents and other related mole-
cules of interest. A, polymeric alkylpyridinium salt (poly-APS) 
a sponge toxin preparation composed of a mixture of two 
polymeric 1,3-octylpyridinium salts of 5.5 (n = 29 average) 
and 19 kDa (n = 99 average) sizes. B, N4,N9-dioleoylspermine 
(LipoGen).
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BMC Biotechnology 2006, 6:6 http://www.biomedcentral.com/1472-6750/6/6ratios for DNA condensation for poly-APS and LipoGen
were at 3.50–4.00 (4.1–4.7 µg/ml) and 1.50–2.50 (3.3–
5.5 µg /ml). All three DNA samples used in our study were
condensed in the same manner by each compound. Inter-
estingly, fluorescence intensity from LipoGen-mediated
DNA condensation experiment decreased much more
sharply than with poly-APS. This superior DNA condensa-
tion effect could be associated with the positive charge
distribution/number and lipophilicity of LipoGen over
poly-APS.
Poration of cell membranes by poly-APS
The measurement of increases in intracellular Ca2+ with
fura-2 can be used as an index of Ca2+ entry through chan-
nels resulting from the interactions of pore forming mol-
ecules with cell membranes [1-3]. Ratiometric
intracellular Ca2+ imaging was conducted to compare pore
formation or permeabilisation of cell membranes by
poly-APS, LipoGen and lipofectamine. Poly-APS (1 µg/
ml) evoked transient increases in intracellular Ca2+ in HEK
293 cells at room temperature (21°C). In contrast Lipo-
DNA condensation profile of poly APS and LipoGen using different DNA; pEGFP (4.7 kilobase pairs), pGL3 (5.3 kilobase pairs) and calf thymus DNA (13 kilobase pairs), using ethidi m bromide displacement and light sc ttering assaysFigure 2
DNA condensation profile of poly APS and LipoGen using different DNA; pEGFP (4.7 kilobase pairs), pGL3 (5.3 kilobase pairs) 
and calf thymus DNA (13 kilobase pairs), using ethidium bromide displacement and light scattering assays. Ethidium bromide 
assay shows a decrease of fluorescence intensity (excitation at 260 nm, and emission at 600 nm) when poly-APS (A) or Lipo-
Gen (B) concentration was increased, expressed in a mole ratio of ammonium/DNA phosphate (N/P). Both poly-APS (4.1–4.7 
µg/ml) and LipoGen (3.3–5.5 µg /ml) condense DNA efficiently with 10% residual fluorescence at N/P ratios 3.5 – 4.0 and (N/
P) 1.5 – 2.5 respectively, (n = 3 for all experiments, error bars represent standard deviation). Light scattering confirmed that 
cationic vector-DNA complexes were formed, (C) for poly-APS, (D) for LipoGen, as the apparent absorbance at 320 nm 
increases significantly from the DNA only control solution.
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Records of fura-2 Ca2+ imagingFigu e 3
Records of fura-2 Ca2+ imaging. A, average (mean; n = 30 HEK 293 cells) trace showing that LipoGen (1 µg/ml) failed to cause 
a rise in intracellular Ca2+ but that polymeric alkylpyridinium salt (Poly-APS; 1 µg/ml) increased intracellular Ca2+ measured as a 
change in fluorescence ratio (Fl.R). The rise in intracellular Ca2+ was indicative of pore formation. Inset record shows a trace of 
changes in intracellular Ca2+ from a single cell. B, average (mean; n = 19 HEK 293 cells) trace showing that lipofectamine (1 µg/
ml) failed to cause a rise in intracellular Ca2+ but that polymeric alkylpyridinium salt (Poly-APS; 1 µg/ml) increased intracellular 
Ca2+, indicative of pore formation. Inset record shows a trace of changes in intracellular Ca2+ from a single cell. C, single cell 
trace of a Ca2+ transient evoked at 12°C by poly-APS.
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BMC Biotechnology 2006, 6:6 http://www.biomedcentral.com/1472-6750/6/6Gen (1 µg/ml) and lipofectamine (1 µg/ml) both failed to
evoke any changes in intracellular Ca2+ indicating that
acute application of these compounds at this concentra-
tion did not result in pore formation in cell membranes
and an increase in Ca2+ permeability (Figure 3A,B). Poly-
APS also efficiently evoked Ca2+ transients at 12°C (Figure
3C).
Dose/response relationships for poly-APS-evoked intrac-
ellular Ca2+ transients were generated at 12°C and at
room temperature (21°C). At 21°C a clear dose-depend-
ent relationship was obtained with 1.0 µg/ml poly-APS
giving significantly larger responses than 0.1 µg/ml poly-
APS (P < 0.005, n = 113 & 56). In contrast at 12°C no clear
dose-dependent relationship was observed with the mean
responses to 1.0 and 0.1 µg/ml poly-APS not being signif-
icantly different. This can be explained by the significantly
larger Ca2+ transients evoked by 0.1 µg/ml poly-APS at
12°C. At 12°C the peak Ca2+ transient had a mean ampli-
tude of 1.0 ± 0.15 fluorescent ratio units (n = 38), at 21°C
the same concentration of poly-APS evoked a significantly
smaller response of 0.43 ± 0.06 fluorescent ratio units (n
= 56; P < 0.001; Figure 4A,B). This effect of temperature
became less apparent at higher concentrations of poly-
APS. At 1.0 µg/ml poly-APS there was no significant differ-
ence between responses obtained at 12°C and 21°C (Fig-
ure 4A). Therefore there was an apparent 10-fold shift in
sensitivity to poly-APS with a 9°C drop in temperature.
The increase in sensitivity of HEK 293 cells to poly-APS at
low temperature was also apparent because a few cells
failed to respond at all to poly-APS applied at 21°C but
subsequently responded well to poly-APS when the tem-
perature was reduced to 12°C. The majority of experi-
ments were conducted by applying poly-APS at room
temperature and then reducing the temperature to 12°C
and reapplying cooled poly-APS. However, temperature
sensitivity was still equally apparent when the experi-
ments were conducted the other way around by firstly
applying poly-APS at 12°C and then raising the tempera-
ture to 21°C and reapplying poly-APS. The changes in
temperature sensitivity to poly-APS were readily reversible
within 5 to 10 min of a temperature increase or decrease.
Intracellular delivery of lucifer yellow
Experiments into pore formation were also conducted
using lucifer yellow as a probe. Although lucifer yellow
has a low molecular weight (457.25 Da) it is a convenient
dye to assess changes in membrane integrity. In the
absence of poly-APS, no lucifer yellow was found intracel-
lularly, this was irrespective of the incubation periods of
1, 2 and 3 h and temperature, 7°C, 21°C and 37°C. Sim-
ilarly, no intracellular delivery of lucifer yellow was
achieved using poly-APS at an incubation temperature of
37°C. However, low levels of intracellular delivery of luci-
fer yellow, was seen with poly-APS at an incubation tem-
perature of 21°C. We estimate that at 21°C intracellular
loading with lucifer yellow was seen in about 5 % of HEK
293 cells, but that this loading into individual cells was
intense (Figure 5A). In contrast, when incubations were
carried out at 7°C poly-APS achieved efficient loading of
lucifer yellow into at least 90 % of cells (Figure 5B). Fur-
thermore, the loaded lucifer yellow remained in these
cells after returning the cells to culture medium and incu-
bating them in standard culture media at 37°C for 24 h.
In contrast little (21°C) or no (7°C) lucifer yellow uptake
was observed when HEK 293 cells were incubated with
Temperature sensitivity of poly-APS actionsFigur  4
Temperature sensitivity of poly-APS actions. A, dose/
response relationship for poly-APS-evoked Ca2+ transients at 
room temperature (21°C, filled squares) and at 12°C (filled 
triangles). At each concentration of poly-APS, larger 
responses were obtained at the lower temperature. The dif-
ferent n values reflect variable sensitivities of HEK 293 cells 
to poly-APS with cells being more sensitive at lower temper-
atures. B, an example record showing larger increases in 
intracellular Ca2+ (Fl.R Fluorescence Ratio units) in response 
to poly-APS at 12°C compared with 21°C.
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BMC Biotechnology 2006, 6:6 http://www.biomedcentral.com/1472-6750/6/6either lipofectamine (4 µg/ml; Figure 5C,D) or LipoGen
(4 µg/ml; Figure 5E,F).
pEGFP delivery by poly-APS and lipopolyamines
Given that pore formation in cell membranes could be
achieved at 12°C with poly-APS, we examined whether
lipofectamine, LipoGen and poly-APS would still func-
tion as transfection reagents at lower temperatures. For
these experiments different incubation protocols were
used for lipofection systems and for poly-APS. A standard
protocol forming complexes between lipofectamine and
DNA and LipoGen and DNA was used but for poly-APS to
work poly-APS was applied separately to cells to allow
pore formation before adding DNA [2]. Incubation proto-
cols with HEK 293 cells, lipofectamine and poly-APS at
12°C still resulted in delivery of cDNA encoding for the
expression of enhanced green fluorescent protein and
transfection with both reagents (Figure 6A,B). Lipo-
fectamine was less efficient as a transfection reagent at
12°C with about 30–50 % of HEK 293 cells transfected
compared with 75–80 % transfection at 37°C. With poly-
APS the transfection efficiency was 20–30 % at 12°C and
therefore similar to that achieved at 37°C [2]. Lipofection
systems were also assessed at 12°C and 37°C using the
same transfection condition and HtTA HeLa cells. There
was a significant decrease of gene expression at 12°C (Fig-
ure 6C), compared to transfection and gene expression at
37°C normally used for optimal cell growth. This data
suggests that LipoGen and lipofectamine-mediated trans-
fection requires endocytosis, and probably does not work
to any great degree through the pore formation mecha-
nism.
Intracellular delivery and function of siRNA
Given the abilities of poly-APS, lipofectamine and Lipo-
Gen to act as transfection reagents for cDNA we were
interested to determine whether they would deliver siRNA
into HEK 293 cells. For these experiments initial incuba-
tion protocols were carried out at 37°C because at this
temperature transfection with cDNA has been achieved
with all three reagents used. The intracellular delivery of
siRNA was detected firstly by visualisation of intracellular
siRNA labelled with fluorescein and secondly by evaluat-
ing knockdown of specific protein expression. Experi-
ments using lipofectamine showed that in the presence of
serum substantial knockdown in protein expression was
observed after 48 h. In contrast when incubations were
carried out in serum-free conditions substantial knock-
down could be identified after 24 h but knockdown did
not increase further after 48 h. Therefore in all other exper-
iments serum-free incubation conditions were used and
analysis of protein knockdown was carried out after 24 h.
Figures 7A&B show intracellular fluorescence produced by
the fluorescein-labelled siRNA delivered into HEK 293
cells using lipofectamine or LipoGen. No intracellular flu-
orescence was observed under control conditions, in the
absence of any transfection reagent (cells incubated with
siRNA alone) or when 1.0 µg/ml poly-APS was used to
porate the cell membrane. In the presence of poly-APS
intracellular fluorescence of fluorescein-labeled siRNA
was not seen even if the siRNA concentration was
increased 4-fold. Additional experiments were conducted
at a lower temperature to increase poly-APS-mediated
pore formation. When incubations were carried out with
poly-APS and siRNA conjugated with fluorescein at 12°C
for 5 h no intracellular delivery of the siRNA was detected
(n = 4). The presence or absence of 10 % serum did not
influence either the activity of lipofectamine or the inac-
tivity of poly-APS (Figure 8A). The delivery of siRNA spe-
cific for β-actin, using lipofectamine or LipoGen had
Temperature effects were also seen when poly-APS was used for intracellular delivery of lucifer yellowFigur  5
Temperature effects were also seen when poly-APS was used 
for intracellular delivery of lucifer yellow. In the absence of 
poly-APS no intracellular uptake of lucifer yellow was 
observed over a 3 h incubation period. After incubation with 
poly-APS and lucifer yellow (1 mM) for 3 h at 21°C a few 
individual cells were loaded (A), but after incubation at 7°C 
almost all cells are filled with lucifer yellow (B). Lipofectamine 
and LipoGen did not deliver lucifer yellow efficiently. Merged 
transmission and fluorescence images show that a very mod-
est amount of fluorescence was observed after incubation 
with lipofectamine and lucifer yellow (1 mM) for 3 h at 21°C 
(C) and no cells were loaded at 7°C (D). Similarly, with Lipo-
Gen, little fluorescence was seen after incubation at 21°C (E) 
and no cells were loaded at 7°C (F).
E LipoGen (21oC) F LipoGen (7oC)
A Poly-APS (21oC) B Poly-APS (7oC)
C Lipofectamine (21oC) D Lipofectamine (7oC)Page 6 of 12
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sion by 30 % (max knockdown 34 & 65 % respectively)
compared to β-actin expression in control cells (Figure
8B,C). The levels of β-actin seen in cells exposed to poly-
APS and siRNA specific for β-actin were comparable with
those measured for the controls but significantly (P
<0.005) higher than the levels seen after lipofectamine or
LipoGen mediated delivery of siRNA (Figure 9).
Discussion
Poly-APS is a highly efficient DNA condensing agent with
an additional property of being able to reversibly form
pores in membranes, which are highly desirable character-
istics for any non-viral vectors. In addition to cell entry
facilitation, this membrane perturbation could also help
in endosomal escape process, which is one of key barriers
in gene delivery. The structure modification of poly-APS
i.e. lipid conjugation, alkyl chain length control and
degree of polymerisation, may further improve its DNA
condensing, pore formation, transfection efficiency, and
toxicity profiles.
Other pyridinium compounds have proved useful trans-
fection reagents, these include the SAINT (synthetic
amphiphile INTeraction) series [8], which have high
transfection efficiency when used in a liposomal formula-
tion with 1,2-dioleoyl phosphatidylethanolamine
(DOPE). The SAINT series are conjugations of two fatty
acid chains (tail group) with pyridinium head groups.
From structure-activity relationship studies, it was found
that unsaturated fatty chains enhanced the transfection
efficiency. Head group modification by introducing
another pyridinium group linked with an alkyl spacer,
also significantly improved the transfection efficiency.
Interestingly, C4 spacer (in SAINT-3) linking two pyridin-
ium heads shows the highest efficiency in DNA delivery,
compared to C3 and C5 spacers [8]. Lipophilicity and
alkyl chain length modifications of poly-APS, leading to
Effect of temperature on gene deliveryFigure 6
Effect of temperature on gene delivery. A, confocal image showing expression of enhanced green fluorescent protein in HEK 
293 cells after transfection at 12°C with poly-APS (0.5 µg/ml; 2.5 µg pEGFP). B, fluorescence microscope image showing 
expression of enhanced green fluorescent protein in HEK 293 cells after transfection at 12°C with lipofectamine (4 µg/200 µl; 
1 µg pEGFP). After incubation at 12°C for cDNA delivery, cells were returned to standard culture media and conditions and 
incubated at 37°C for 24 h before being examined. C, Histogram showing the temperature dependence of gene delivery to 
HtTA HeLa cells. pEGFP DNA complexed with LipoGen (N/P ratio 2.5 and 5.0) and Lipofectamine (N/P ratio 3.0) were added 
into each well of HtTA HeLa cells (cervix carcinoma, 50% confluent) in serum-free media. Transfection experiments were per-
formed at 37°C or 12°C, and then DNA complexes were removed after 4 h exposure. The number of fluorescent cells was 
determined by FACS cytometry after 44 h post-transfection at 37°C, to determine the efficiency of pEGFP delivery systems. 
Significant decrease of transfection efficiency at 12°C was found in all lipofection systems used, compared with standard trans-
fection conditions at 37°C. (n = 3 for all transfections, three replicates each, error bars represent standard deviation).
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tance between pyridinium head-groups in the poly-APS
molecules) may in the future improve pore formation and
transfection properties of modified poly-APS.
Previously, we have shown that a sponge toxin prepara-
tion, poly-APS, can produce pores in cell membranes and
perform as a transfection reagent. This is unusual given
that poly-APS is a natural product preparation and it raises
the possibility that in nature as well as acting in chemical
defence, polymeric alkypyridinium compounds may also
provide a novel mechanism of natural horizontal genetic
material transfer between marine microorganisms. The
mechanism by which poly-APS delivers macromolecules
into cells and achieves transfection is unknown. However,
reversible pore formation by poly-APS and movement of
macromolecules down concentration or electrochemical
gradients into cells through these structures may provide
a novel mechanism for the intracellular delivery of nor-
mally impermeant molecules. An alternative mechanism
might involve the binding of poly-APS to cDNA, this com-
plex binding to cell membranes and then internalisation
by endocytosis. The processes of endocytosis are tempera-
ture dependent as temperature affects both rate of ligand
binding and mobility of ligand-receptor complexes in
membranes. Endocytotic processes are usually blocked at
temperatures below 12°C. For example lucifer yellow
uptake into platelets by fluid phase endocytosis occurs
above 15°C [13]. Although platelets clearly load with
lucifer yellow at 37°C no such uptake was seen at this
temperature in HEK 293 cells. However, dramatic stable
intracellular loading of lucifer yellow into HEK 293 cells
was facilitated by poly-APS during low temperature incu-
bations. This event was not supported by lipofectamine or
LipoGen and must therefore be due to some processes
other than fluid phase endocytosis. Experiments were
conducted to determine whether poly-APS would perme-
abilise cells, as reflected by calcium influx, support trans-
fection of cDNA encoding for the expression of enhanced
green fluorescent protein and delivery of lucifer yellow
into cells at 7–12°C. At low temperatures, poly-APS func-
tions well, both as a pore former and as a transfection rea-
gent for delivery of cDNA. This indicates that endocytosis
is unlikely to be the mechanism by which poly-APS deliv-
ers cDNA and lucifer yellow into cells. Additionally, the
protocol used for cDNA delivery also suggests that endo-
cytosis is not involved because there is a requirement to
incubate cells in poly-APS prior to exposure with cDNA.
Furthermore, the temperature data adds to the evidence
(pre-mixing poly-APS with cDNA actually prevents trans-
fection), that pore formation by poly-APS is critical for
macromolecule delivery. Although lipofectamine and
LipoGen could be used as a transfection reagent at 12°C
they were much less efficient at low temperatures com-
pared to high temperatures. A further difference was the
failure of lipofectamine and LipoGen to cause an increase
in intracellular Ca2+, therefore these reagents show very
different biological activity compared to poly-APS.
The polymeric structure of poly-APS appears critical to at
least some of its biological activities. We previously found
that two monomeric compounds, cetylpyridinium chlo-
ride and cetyltrimethylammonium bromide, did not
reversibly permeate cell membranes and did not support
transfection [14]. A recent investigation on poly-APS and
synthetic linear alkylpyridinium monomers, dimers and
tetramers showed that biological activities such as anti-
bacterial, hemolytic activities, anti-acetylcholinesterase
activities and inhibition of protein phosphatase 2A are
greatly and differentially influenced by increasing num-
bers of positive charges and pyridinium rings. The smaller
synthetic compounds showed good anti-enzymatic and
antibacterial activity. In contrast poly-APS showed much
greater hemolytic activity compared to the smaller syn-
thetic compounds [15].
Delivery of siRNA with lipofectamine and LipoGen into HEK 293 c llsFigure 7
Delivery of siRNA with lipofectamine and LipoGen into HEK 
293 cells. Intracellular delivery of siRNA fluorescein conju-
gate using A, lipofectamine and B, LipoGen as transfection 
reagents was visualised as confocal transmission images after 
a 4.5 h incubation period. No siRNA-positive cells were 
observed in the absence of a transfection reagent or after 
incubation with poly-APS. The left-hand images are fluores-
cent images and the right-hand images are corresponding 
transmission images.
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enhances pore formation by poly-APS both at the lowest
concentration of poly-APS tested (0.1 µg/ml) and in cells
that were less sensitive and failed to respond to poly-APS
at room temperature. It is likely that this effect is due to
both temperature-dependent alterations in physicochem-
ical properties of the cell membrane and conformational
changes in poly-APS resulting in promotion of poly-APS
insertion into the membrane and pore formation. How-
ever, poly-APS did not deliver siRNA or knockdown pro-
tein, whereas both lipofectamine and LipoGen delivered
siRNA and produced specific knockdown of functional β-
actin similarly. It is not clear why siRNA was not delivered
into HEK 293 cells.
Conclusion
In conclusion, poly-APS was found to be an efficient pore
former and at low temperatures (7–12°C) could deliver
into cells both cDNA and lucifer yellow but not siRNA. In
the future it would be interesting to evaluate the binding
of siRNA to poly-APS and its influences on pore forma-
tion. It is noteworthy that pyridinium salts are efficient
quenching agents reflecting binding properties. Although
quenching might have accounted for the negative result
obtained when we attempted to deliver fluorescein-
labeled siRNA with poly-APS, it does not explain the neg-
ative results with siRNA targeted against β-actin. In con-
trast to poly-APS, LipoGen and lipofectamine did not
form Ca2+ permeant pores, but did deliver siRNA into cells
and are likely to function in a similar manner. Further
studies of the temperature sensitivity to poly-APS might
provide approaches, using low temperature and low poly-
APS concentrations, to improve efficiency and selectively
delivery of macromolecules into cells. In the context of the
negative temperature coefficient for poly-APS, it is inter-
esting to note that newly discovered 1,3-dialkylpyridin-
ium and related compounds have been extracted from
Arctic species of sponges [19-21]. These findings show
that alkylpyridinium compounds are not confined to tem-
perate and tropical Haplosclerida but may contribute to
host defence in cold environments.
Methods
Materials
Poly-APS (C13H20N+ monomer M.W. 190.16, [4] with one
positive charge per monomer unit) were purified from the
Adriatic marine sponge Reniera sarai as previously
described [4], and dissolved in MilliQ water (stock solu-
tion 1 µg/µl) [1-3]. Poly-APS is readily solubilized in dis-
tilled water at room temperature and can be kept for
months at 4°C without loosing biological activities. We
have never observed any precipitation at 4°C when poly-
APS was kept at concentrations up to 1.5 mg/ml. How-
ever, the solubility is highly dependant on the polarity of
the solvent and poly-APS is only poorly soluble in meth-
anol, and even less soluble in ethanol. There is only very
limited data on phase behaviour of poly-APS in water.
Experiments with dynamic and static light scattering [4]
have shown that poly-APS exists as a mixture of monomo-
lecular polymers, creating large supramolecular spherical
aggregates with a hydrodynamic radius of 23 nm.
N4,N9-dioleoylspermine (LipoGen) [5,7] was synthesized
by the procedure described elsewhere [16]. LipoGen was
dissolved in ethyl alcohol (stock solution 2 µg/µl). Buffers
and NaCl solution were also made up in MilliQ water and
buffers were adjusted to 7.4 with aq. NaOH solution.
Lipofectamine was purchased from Invitrogen, U.K.
pEGFP (4.7 kbp) and pGL3 (5.3 kbp) DNA were prepared
Delivery of β-actin siRNA using lipofectamine knocked down β-actinFigure 8
Delivery of β-actin siRNA using lipofectamine knocked down 
β-actin. A, Western blots of β-actin expression in HEK 293 
cells and knockdown by delivery of β-actin siRNA using lipo-
fectamine (Lipofect), but not poly-APS, in the absence of 
serum in the incubation media for 3 h and 6 h. The presence 
of 10 % serum has been shown to attenuate poly-APS-medi-
ated pore formation, so experiments were conducted in 
serum-free conditions. B, shows a standard loading record 
for NFKB for the Western blots of siRNA knockdown of β-
actin by LipoGen, poly-APS and lipofectamine (Lipofect) illus-
trated in part C of this figure. C, Western blots for siRNA 
knockdown of β-actin by LipoGen, lipofectamine (Lipofect) 
and poly-APS.
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purification protocol and stored in a freezer before use.
Calf thymus DNA was purchased from Sigma-Aldrich
U.K. Foetal calf serum (FCS), 10 × Minimum essential
media (MEM), Penicillin G, Streptomycin, L-glutamine,
7.5% NaHCO3, trypsin, PBS, and serum-free MEM (Opti-
MEM) were obtained from Gibco-Invitrogen.10% Media
used during transfection complexes addition was either
NaCl-based saline or serum-free MEM. Other chemicals
used were supplied from Sigma-Aldrich U.K.
DNA condensation
The displacement assay fluorescence measurements were
run with Perkin-Elmer Fluorescence Spectrophotometer
Model LS50B (λ ex = 260 nm, λ em = 600 nm, 1 cm path-
length, 3 ml glass cuvette, slit width 5 nm) with FLWinLab
version 2.00 for data processing. DNA concentration and
purity were carried out with a Helios UV spectrophotom-
eter at 260 nm (for DNA concentration) and 280 nm (for
protein concentration) prior to the experiments [20].
DNA (6 µg) was obtained from the stock solution and
diluted to 3 ml with low-NaCl HEPES buffer (2 mM
HEPES, 20 mM NaCl, 10 µM EDTA, pH 7.4) in a glass
cuvette stirred with a micro-flea. Immediately prior to
analysis, EthBr solution (3 µl, 0.5 µg/µl) was added to the
DNA solution, stirred for 1 min to equilibrate the binding
process. Aliquots of poly-APS or LipoGen were added to
the stirring DNA solution at the desired ammonium/
phosphate (N/P) ratio and the fluorescence measured
after 1 min equilibration [20,21]. Optimal N/P ratios for
DNA condensation for poly-APS and LipoGen were at
3.50–4.00 (4.1–4.7 µg/ml) and 1.50–2.50 (3.3–5.5 µg /
ml). The emission intensity was reported as the percent-
age of maximum fluorescence (100 %) when DNA was
fully intercalated by EthBr without the DNA binding
agents and corrected for the background fluorescence of
total EthBr in buffer solution.
For the light scattering assay, DNA (60 µg) was taken from
the DNA stock solution and diluted to 3 ml with HEPES
buffer (2 mM HEPES, 20 mM NaCl, 10 µM EDTA, pH 7.4)
in a glass cuvette stirred with a micro-flea. Aliquots of
poly-APS or LipoGen were added to the stirring DNA solu-
tion at the desired N/P ratio and the UV absorbance at 320
nm was then measured after I min equilibration [21].
HEK 293 cell cultures
HEK 293 cells (human embryonic kidney cell line) were
maintained in culture in Dulbecco's modified Eagle's
minimum essential medium, supplemented with 10 %
foetal calf serum, 2 mM L-glutamine, 50 µU/ml penicillin,
50 µg/ml streptomycin and 1 % non-essential amino
acids. In preparation for experiments and 24 h prior to
experimentation, cells were seeded at a density of 0.5 mil-
lion cells per 35 mm dish.
HtTA HeLa cell cultures
HtTA-1 HeLa cells, at 1 × 106 cells, were grown in 150 ml
flask with 25 ml of 10% FCS EMEM (minimum essential
media with penicillin, streptomycin, glutamine, sodium
bicarbonate, and 10% foetal calf serum) [22-24]. Each
500 ml of media contained 50 ml EMEM (10×), 13.5 ml
NaHCO3 (7.5%), 5 ml L-glutamine (200 mM), 25000 IU
penicillin G, 25000 µg streptomycin and 10% foetal calf
serum. The culture was incubated at 37°C, 5% CO2. The
cells were passaged every 3 days. Trypsinized cells were
added to the next passage at 1 × 106 cells/flask.
Ca2+ imaging
Ca2+ imaging experiments were conducted at room tem-
perature (approximately 21°C) or 12°C. HEK 293 cells
were bathed in a NaCl-based extracellular solution con-
taining in mM: NaCl, 130; KCl, 3.0; CaCl2, 2.0; MgCl2,
0.6; NaHCO3 1.0, HEPES 10.0, glucose 5.0. The pH and
osmolarity of extracellular solutions were adjusted to 7.4
and 310–320 mOsmol/l with NaOH and sucrose respec-
tively.
Cultured HEK 293 cells were incubated for 1 h in NaCl-
based extracellular solution containing 10 µM fura-2AM
(Sigma, 1 mM stock in dimethylformamide) and the
effects of poly-APS, lipofectamine and LipoGen on intrac-
ellular Ca2+ were evaluated using fluorescence ratiometric
imaging as previously described [1-3]. For some experi-
ments, the temperature was changed by perfusing cells
with saline at 21°C and 12°C. The temperature was mon-
Histogram showing normalised data for siRNA knockdown of β-actin and the effect of different tran fection reagentsFigure 9
Histogram showing normalised data for siRNA knockdown 
of β-actin and the effect of different transfection reagents. All 
data are represented as mean percentage expression relative 
to the control. Data analyses conducted after 24 or 48 h are 
included.
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placed in the bath containing the cells. All data are given
as mean ± standard error of the mean and statistical signif-
icance was determined using the Student's two-tailed
unpaired t test.
Macromolecule and probe delivery protocols
cDNA delivery into HEK293 cells
HEK 293 cells were washed with NaCl-based saline or
serum-free medium, then exposed to 0.5 µg/ml poly-APS
for 5 min and then poly-APS and 2.5 µg/ml cDNA encod-
ing for the expression of enhanced green fluorescent pro-
tein (pEGFP; Clontech) for 3 h at 12°C.
Additionally, experiments were conducted using lipo-
fectamine as the transfection reagent. Lipofectamine (4
µg) was mixed with 100 µl of serum-free medium and
incubated at room temperature for 5 min prior to adding
to 100 µl of serum-free medium containing cDNA (1 µg/
ml; N/P ratio 4). After mixing this solution containing
transfection reagent and cDNA was incubated for 20 min
at room temperature and then added to the cells. The cells
were incubated for 3 h at 12°C. After incubation with the
transfection reagent and cDNA, serum (to give 10 %) was
added. For cells incubated with NaCl-based saline, serum-
containing medium was added to replace the saline. Cells
were maintained in culture for 24 h before green fluores-
cent protein was examined using either fluorescence
microscopy or confocal imaging.
cDNA delivery into HtTA cells
DNA complex solution for each well was prepared from
solution A and solution B. For solution A, pEGFP (2 µg)
was diluted to 100 µl solution with Opti-MEM medium
(serum-free media). Solution B was prepared from Lipo-
Gen (5.5 and 11.0 µg for N/P ratios of 2.5 and 5.0 respec-
tively), or lipofectamine (2.53 µl for an N/P ratio of 3.0)
was diluted to 100 µl with Opti-MEM medium. Each solu-
tion was left at 20°C for 30 min. Solutions A and B were
then mixed together and vortexed for a brief period, incu-
bated at 20°C for 20 min for DNA complexing. In 6-well
or 12-well tissue culture plates, HtTA 2.5 × 104 cells/ ml
were seeded in 4 ml and 2 ml of 10% FCS EMEM respec-
tively. The cells were incubated at 37°C with 5% CO2 in
an incubator for 24 h, until the cells were 30 – 50% con-
fluent. Prior to the addition transfection complexes,
media was removed and replaced with either NaCl-based
saline or Opti-MEM. NaCl-based extracellular solution
used in HtTA cell experiments was the same as used in
HEK 293 cell experiments. For 12°C experiments, cells
were placed in a temperature-controlled refrigerator for 10
min before the transfection. Solutions of DNA complexes
(200 µl/well) were added, and then cells were incubated
in either 37°C with 5% CO2 or at 12°C. The 48 h post-
transfection samples was analysed by FACS for enhanced
green fluorescent protein level.
Lucifer yellow delivery
HEK 293 cells were washed with NaCl-based saline, then
exposed to 0.5 µg/ml poly-APS for 5 min and then poly-
APS and 1 mM lucifer yellow (Sigma) for 1, 2 and 3 h. Pre-
incubations in poly-APS and incubations in lucifer yellow
were carried at 7°C, 21°C and 37°C. Cells were washed
three times before intracellular loading with lucifer yellow
was evaluated by fluorescence microscopy immediately
after incubation and again after being placed in culture
medium and cultured for a further 24 h. Additionally, the
abilities of lipofectamine (4 µg/ml) and LipoGen (4 µg/
ml) to load HEK 293 cells with lucifer yellow were deter-
mined over 3 h incubation periods at 7°C and 21°C.
siRNA delivery
HEK 293 cells were washed with serum-free medium,
then exposed to 1.0 µg/ml poly-APS for 5 min and then
poly-APS and 200 nM siRNA conjugated with fluorescein
(QIAGEN) for 4 to 6 h at 37°C. An additional set of exper-
iments were carried out with 1.0 µg/ml poly-APS and 200
nM siRNA conjugated with fluorescein (QIAGEN) for 5 h
at 12°C. The fluorescence within the cells was assessed
immediately after incubation using confocal imaging.
Additionally, experiments were conducted using lipo-
fectamine and LipoGen as transfection reagents. Lipo-
fectamine (4 µg) or LipoGen (4 µg) were mixed with 100
µl of serum-free medium and incubated at room temper-
ature for 5 min prior to adding to 100 µl of serum-free
medium containing 50 nM siRNA conjugated with fluo-
rescein. After mixing, this solution containing transfection
reagent and siRNA was incubated for 20 min at room tem-
perature and then added to the cells bathed in 1 ml serum-
free medium (final volume 1.2 ml). The cells were incu-
bated for 4–6 h at 37°C before imaging siRNA intracellu-
lar delivery.
Knockdown of β-actin protein with β-actin specific siRNA
(Ambion) was assessed using Western blot analysis. HEK
293 cells were treated and incubated with transfection rea-
gents (poly-APS, lipofectamine or LipoGen) as above with
100 nM siRNA for lipofectamine and LipoGen or with
333 µM siRNA for poly-APS (ratio 1 µg: 30 pmol siRNA
for lipofectamine and LipoGen and 1 µg: 667 pmol siRNA
for poly-APS) for 3 or 6 h at 37°C. The N/P values for the
siRNA β-actin experiments were approximately 1.3 to 8.8
and 1.6 to 10.8 (2.4 to 0.35 µg/ml siRNA to 4 µg/ml lipo-
fectamine or LipoGen respectively). Serum was then
added (to give a final concentration of 10 %) and then the
cells were maintained in culture for 24 or 48 h. siRNA neg-
ative controls were run with non-homologous siRNA.
Cells were placed on ice and processed for Western blot
protein analysis (Santa Cruz Biotechnology Inc.). LoadingPage 11 of 12
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probing using antibodies for NFKB (Cell Signalling).
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pEGFP plasmid encoding for enhanced green fluorescent
protein
EthBr ethidium bromide
LipoGen N4,N9-dioleoylspermine
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Poly-APS polyalkylpyridinium salts
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siRNA small interfering RNA
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